Tag: MARKET
-
DRC’s Cobalt Export Suspension: Impact on Global Markets
The Democratic Republic of Congo (DRC) has implemented a four-month suspension of cobalt exports, effective February 22, 2025, leading to a surge in global cobalt prices. As the world’s largest supplier, producing around 74% of mined cobalt, this decision has caused cobalt hydroxide prices to rise by 84% to $10.50 per pound, the highest level…
-
Trump Tariffs 2.0 vs. 1.0 – How the S&P 500 is Reacting Now
The market’s reaction to tariff implementations has been a significant indicator of investor sentiment and economic expectations. The chart comparing Trump 1.0 and Trump 2.0 tariffs showcases a clear correlation between the imposition of tariffs and S&P 500 daily returns, with the latter period appearing to be more volatile and reactive. Tariff 1.0: The 2018…
-
Unusual Spike in Put Volume: A Market Turning Point?
On March 4, 2025, the CBOE Total Put Volume surged to 6.18 million contracts, marking the second-highest level in the past five years. This level of put activity exceeds the total volume recorded throughout 2022, raising questions about potential market implications. Historically, extreme spikes in put volume have often been associated with market reversals rather…
-
Market Snapshot: Everything but Gold, ATH again
US Stock Futures Decline Amid Tariff Concerns; Gold Hits Record High US stock futures dipped as concerns over trade tariffs weighed on market sentiment. Contracts on the S&P 500 and Nasdaq 100 slipped by about 0.3%, retreating from recent record highs. Meanwhile, gold surged to an all-time high above $2,954 an ounce amid geopolitical uncertainty…
-
FTX’s Massive Solana Sale: What It Means for Crypto Investors
The collapse of FTX left a financial void, but its estate has been actively liquidating assets to repay creditors. One of its major moves was the sale of 41 million locked Solana (SOL) tokens through three separate auctions. While this sale helped recover funds, it also raised concerns about the potential impact on the Solana…
-
Apple vs. China: A Power Struggle That Could Change Everything
Apple’s relationship with China is entering uncertain territory as regulators in Beijing consider a formal probe into the tech giant’s App Store policies. The scrutiny is focused on Apple’s commission fees—reaching up to 30% on in-app purchases—and restrictions on third-party payment systems and alternative app stores. The State Administration for Market Regulation (SAMR) is leading…
-
Crypto Market Takes a $590 Billion Hit – What’s Driving the Plunge?
The cryptocurrency market has taken a significant hit, with total market capitalization plunging from $3.62 trillion to $3.03 trillion—a staggering $590 billion wiped out in a short span. This drop underscores the volatility inherent in the crypto space, with a mix of macroeconomic trends, regulatory pressures, and investor sentiment playing a role in the downturn.…
-
Surge in Reverse Repo Market Activity Signals Key Liquidity Trends for 2025
The reverse repo market saw notable activity on January 27, 2025, as reported by the Federal Reserve Bank of New York. This activity, marked by a peak overnight reverse repo operation of $200 million on January 24, underscores the financial system’s dynamic liquidity adjustments. Counterparties such as primary dealers, banks, and money market funds participated,…
-
It’s Time to BUY! Not a Fed Overreaction, But Smart Profit-Taking Creates Opportunity
The market pullback yesterday wasn’t just about reacting to the Federal Reserve. What we saw was a textbook example of investment banks taking profits after a year of strong gains, particularly in technology stocks. For everyday investors, this creates a great chance to “buy the dip” before the next rally begins. Let’s break it down.…
-
More Options for Patients by 2027: The Future of Obesity Treatments and Investment Opportunities
The obesity treatment industry is expanding rapidly, creating a significant opportunity for investors. Companies like Novo Nordisk and Eli Lilly have taken the lead in addressing the growing global obesity epidemic with groundbreaking drugs like Ozempic, Wegovy, Zepbound, and Mounjaro. These treatments have driven massive revenue growth, and analysts expect this trend to accelerate as…